DUBLIN--(BUSINESS WIRE)--Nov 15, 2022--
The "In vitro Diagnostics Market Analysis by Products (Instruments, Reagents), by Technology (Immunoassay, Clinical Chemistry, Microbiology), by Application (Oncology, Infectious Diseases, Nephrology, Diabetes, Cardiology), by End user, and by Region - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The global in vitro diagnostics market size is estimated to be USD 99.46 billion in 2021 and is anticipated to witness a CAGR of 3.10% during the forecast period.
Companies Mentioned
Increase in global geriatric population is a key driver for the growth of the global in vitro diagnostics market. Additionally, rise in cases of chronic and infectious diseases and growth in awareness regarding diagnosis of disease in developing economies in the in vitro diagnostics market are some of the other drivers propelling the market growth.
Nevertheless, unfavourable repayment situation and operative obstacles encountered in conducting diagnostic tests in the developed economies are expected to restrain the global market growth.
The in vitro diagnostics market report is categorized into the following segments and subsegments:
In vitro Diagnostics Market, By Product (Revenue, USD Billion, 2021 - 2029)
In vitro Diagnostics Market, By Technology (Revenue, USD Billion, 2021 - 2029)
Immunoassay
Haematology
Clinical Chemistry
Molecular Diagnostics
Coagulation
Microbiology
Others
In vitro Diagnostics Market, By Application (Revenue, USD Billion, 2021 - 2029)
In vitro Diagnostics Market, By End User (Revenue, USD Billion, 2021 - 2029)
In vitro Diagnostics Market, By Region (Revenue, USD Billion, 2021 - 2029)
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
For more information about this report visit https://www.researchandmarkets.com/r/rugrxd
View source version on businesswire.com:https://www.businesswire.com/news/home/20221115006096/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: GENERAL HEALTH HEALTH TECHNOLOGY HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 11/15/2022 10:08 AM/DISC: 11/15/2022 10:08 AM
http://www.businesswire.com/news/home/20221115006096/en